Literature DB >> 8579059

Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndrome.

F J Esteva-Lorenzo1, K R Meehan, T R Spitzer, A Mazumder.   

Abstract

We describe a 32-year-old man with idiopathic hypereosinophilic syndrome (HES) who presented with pulmonary dysfunction, thrombocytopenia, lymphadenopathy, and hepatosplenomegaly. The patient developed progressive disease on prednisone and hydroxyurea therapy, and he underwent a successful allogeneic bone marrow transplantation (BMT). The patient is asymptomatic with no evidence of eosinophilia 30 months after transplantation. There is currently no cure for patients with HES, and BMT should be considered in selected patients.

Entities:  

Mesh:

Year:  1996        PMID: 8579059     DOI: 10.1002/(SICI)1096-8652(199602)51:2<164::AID-AJH12>3.0.CO;2-I

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

2.  Successful treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate: a case report.

Authors:  D Tan; W Hwang; H J Ng; Y T Goh; P Tan
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.